Towards a high resolution separation of human cerebrospinal fluid.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

• Publication date

  2002-05-05

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S1570-0232(01)00626-2PMID 12015998
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurobiology of Cerebrospinal Fluid 1

  2012cited by this paper
• IDENTIFICATION OF MODIFIED PEPTIDES BY METASTABLE FRAGMENTATION IN MALDI MASS SPECTROMETRY

  1997cited by this paper
• Instrumental requirements for nanoscale liquid chromatography.

  1996cited by this paper
• Characterization of SDS--PAGE-separated proteins by matrix-assisted laser desorption/ionization mass spectrometry.

  1996cited by this paper
• Solubilization of proteins for electrophoretic analyses

  1996cited by this paper
• Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database.

  1995cited by this paper
• Mining genomes: correlating tandem mass spectra of modified and unmodified peptides to sequences in nucleotide databases.

  1995cited by this paper
• An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database

  1994cited by this paper
• Sequenching of peptides in a time-of-flight mass spectrometer: evaluation of postsource decay following matrix-assisted laser desorption ionisation (MALDI)

  1994cited by this paper
• Rapid identification of proteins by peptide-mass fingerprinting.

  1993cited by this paper
• Metastable decay of peptides and proteins in matrix‐assisted laser‐desorption mass spectrometry

  1991cited by this paper
• Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G‐250 and R‐250

  1988cited by this paper
• Simplified method for silver staining of proteins in polyacrylamide gels and the mechanism of silver staining

  1985cited by this paper
• Physiology, Pharmacology, and Dynamics of Cerebrospinal Fluid

  1980cited by this paper

• N-glycan profile of cerebrospinal fluids from Alzheimer's Disease patients using LC-MS.

  2019cites this paper
• Deep Dive on the Proteome of Human Cerebrospinal Fluid: A Valuable Data Resource for Biomarker Discovery and Missing Protein Identification.

  2018cites this paper
• NUCLEC ACDS AND OTHER ANALYTES

  2017cites this paper
• Cerebrospinal fluid in Creutzfeldt-Jakob disease.

  2017cites this paper
• Proteomic Biomarker Identification in Cerebrospinal Fluid for Leptomeningeal Metastases with Neurological Complications.

  2017cites this paper
• Graphene nanosheet mediated MALDI-MS (GN-MALDI-MS) for rapid, in situ detection of intact incipient biofilm on material surfaces.

  2016cites this paper
• Label‐free quantitative comparison of cerebrospinal fluid glycoproteins and endogenous peptides in subjects with Alzheimer's disease, mild cognitive impairment, and healthy individuals

  2016cites this paper
• A comprehensive map and functional annotation of the normal human cerebrospinal fluid proteome.

  2015cites this paper
• Structural features of the low-molecular-weight plasma fraction in far eastern redfins of the genus Tribolodon and other cyprinid fishes

  2015cites this paper
• Las proteínas y aminoácidos del líquido cefalorraquídeo

  2015cites this paper
• Identification of Nitrated Immunoglobulin Variable Regions in the HIV-Infected Human Brain: Implications in HIV Infection and Immune Response

  2014cites this paper
• Crosstalk in human brain between globoid cell leucodystrophy and zinc-α-2-glycoprotein (ZAG), a biomarker of lipid catabolism.

  2013cites this paper
• Non-aqueous microchip electrophoresis for characterization of lipid biomarkers

  2013cites this paper
• The challenge to quantify proteins with charge trains due to isoforms or conformers

  2012cites this paper
• Identification of oxidized serum albumin in the cerebrospinal fluid of ischaemic stroke patients

  2011cites this paper
• Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics.

  2011cites this paper
• Profiling cerebrospinal fluid proteins in Alzheimer's disease

  2011cites this paper
• Proteomic Analysis of CNS Injury and Recovery

  2011cites this paper
• Highly selective and sensitive enrichment of phosphopeptides via NiO nanoparticles using a microwave-assisted centrifugation on-particle ionization/enrichment approach in MALDI-MS

  2011cites this paper
• Proteome analysis of human aqueous humor.

  2010cites this paper
• Metabolic profiling of Escherichia coli by ion mobility-mass spectrometry with MALDI ion source.

  2010cites this paper
• Malignant transformation in a defined genetic background: proteome changes displayed by 2D-PAGE

  2010cites this paper
• BEYOND BIOMARKER DISCOVERY: RETINOID SIGNALING IN MOTOR NEURONS AND AMYOTROPHIC LATERAL SCLEROSIS

  2010cites this paper
• Anti-inflammatory therapy and cerebrospinal fluid diagnosis in Alzheimer's disease.

  2010cites this paper
• Novel HPLC-ICP-MS strategy for the determination of beta2-transferrin, the biomarker of cerebrospinal fluid (CSF) leakage.

  2010cites this paper
• Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme.

  2010cites this paper
• Proteomics in human Parkinson's disease research.

  2009cites this paper
• A comprehensive proteome map of bovine cerebrospinal fluid

  2009cites this paper
• Trace elements in cerebrospinal fluid and blood from patients with a rare progressive central and peripheral demyelinating disease.

  2008cites this paper
• High resolution inductively coupled plasma mass spectrometry: Some applications in biomedicine

  2008cites this paper
• An aberrant protein complex in CSF as a biomarker of Alzheimer disease

  2008cites this paper
• Proteomics of Human Neurodegenerative Diseases

  2008cites this paper
• Characterization of the human cerebrospinal fluid phosphoproteome by titanium dioxide affinity chromatography and mass spectrometry.

  2008cites this paper
• Proteomics of brain extracellular fluid (ECF) and cerebrospinal fluid (CSF).

  2008cites this paper
• Learning predictive models for combinations of heterogeneous proteomic data sources

  2008cites this paper
• 7.1 Proteomics

  2007cites this paper
• Enhancing the analysis of mass-spectrometry proteomic profiles using prior knowledge and past data repositories

  2007cites this paper
• Identification of Early Markers for Symptomatic Vasospasm in Human Cerebral Microdialysate after Subarachnoid Hemorrhage: Preliminary Results of a Proteome-Wide Screening

  2007cites this paper
• Separation of proteins including metallothionein in cerebrospinal fluid by size exclusion HPLC and determination of trace elements by HR-ICP-MS.

  2007cites this paper
• Proteomics of human cerebrospinal fluid – the good, the bad, and the ugly

  2007cites this paper
• CSF biomarker discovery using label-free nano-LC-MS based proteomic profiling: technical aspects.

  2007cites this paper
• Methods for samples preparation in proteomic research.

  2007cites this paper
• Proteomics of traumatic brain injury and regeneration

  2007cites this paper
• Current state and future directions of neurochemical biomarkers for Alzheimer's disease.

  2007cites this paper
• Proteomics of Human Cerebrospinal Fluid

  2007cites this paper
• Toward the complete yeast mitochondrial proteome: multidimensional separation techniques for mitochondrial proteomics.

  2006cites this paper
• Identification of brain cell death associated proteins in human post-mortem cerebrospinal fluid.

  2006cites this paper
• Approaches to the Identification of Novel Diagnostic and Therapeutic Targets in Dementia

  2006cites this paper
• Identification of glycoproteins in human cerebrospinal fluid with a complementary proteomic approach.

  2006cites this paper
• CSF-studies in neuropsychiatric disorders.

  2006cites this paper
• Lumbar cerebrospinal fluid proteome in multiple sclerosis: characterization by ultrafiltration, liquid chromatography, and mass spectrometry.

  2006cites this paper
• An improved method for Dictyostelium centrosome isolation.

  2006cites this paper
• Mass spectrometry for comparative proteomics of degenerative and regenerative processes in the brain

  2006cites this paper
• Differential post‐translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid

  2006cites this paper
• Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry: Towards new diagnostic and therapeutic approaches

  2005cites this paper
• A proteomic analysis of murine bone marrow and its response to ionizing radiation

  2005cites this paper
• Immunoglobulin Patterns in Health and Disease

  2005cites this paper
• Human cerebrospinal fluid peptidomics.

  2005cites this paper
• Proteomics analysis of prefractionated human lumbar cerebrospinal fluid

  2005cites this paper
• Proteomics analysis of human cerebrospinal fluid.

  2005cites this paper
• The impact of blood contamination on the proteome of cerebrospinal fluid

  2005cites this paper
• Alzheimer's disease cerebrospinal fluid biomarker discovery: a proteomics approach.

  2005cites this paper
• Evaluation of protein depletion methods for the analysis of total-, phospho- and glycoproteins in lumbar cerebrospinal fluid.

  2005cites this paper
• Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid.

  2005cites this paper
• Pigment epithelium‐derived factor is differentially expressed in peripheral neuropathies

  2005cites this paper
• Diagnostic de maladies neurodégénératives

  2005cites this paper
• Brain injury and proteomics/peptidomics: is it relevant? an overview.

  2005cites this paper
• CSF proteome: a protein repository for potential biomarker identification

  2005cites this paper
• Cerebrospinal fluid protein patterns in neurodegenerative disease revealed by liquid chromatography‐Fourier transform ion cyclotron resonance mass spectrometry

  2004cites this paper
• Extracellular matrix components associated with remodeling processes in brain

  2004cites this paper
• Mining the human cerebrospinal fluid proteome by immunodepletion and shotgun mass spectrometry

  2004cites this paper
• Optimized sample-processing time and peptide recovery for the mass spectrometric analysis of protein digests

  2004cites this paper
• Miniaturized proteomics and peptidomics using capillary liquid separation and high resolution mass spectrometry

  2004cites this paper
• Towards two‐dimensional electrophoresis mapping of the cerebrospinal fluid proteome from a single individual

  2004cites this paper
• Proteomic analysis of multiple sclerosis cerebrospinal fluid

  2004cites this paper
• Functional genomics and proteomics: application in neurosciences

  2004cites this paper
• In-depth analysis of the human CSF proteome using protein prefractionation

  2004cites this paper
• Liquid chromatographic-fluorimetric method for the estimation of nitric oxide biosynthesis in the central nervous system.

  2004cites this paper
• Electrifying the Molecules of Life : Peptide and Protein Analysis by Capillary Electrophoresis Coupled to Electrospray Ionization Mass Spectrometry

  2004cites this paper
• Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients

  2004cites this paper
• High throughput approaches in neuroscience

  2004cites this paper
• Validation of a prefractionation method followed by two-dimensional electrophoresis – Applied to cerebrospinal fluid proteins from frontotemporal dementia patients

  2004cites this paper
• Peptide and Protein Analysis by Capillary Electrophoresis Coupled to Electrospray Ionization Mass Spectrometry

  2004cites this paper
• Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease.

  2003cites this paper
• Proteomics in 2002: a year of technical development and wide-ranging applications.

  2003cites this paper
• Proteomics analysis of phosphotyrosyl-proteins in human lumbar cerebrospinal fluid.

  2003cites this paper
• Improved resolution of human cerebrospinal fluid proteins on two-dimensional gels

  2003cites this paper
• The proteome of Saccharomyces cerevisiae mitochondria

  2003cites this paper
• Peptid-induzierte Antikörper als hochspezifische Werkzeuge der modernen Proteom-Analyse

  2003cites this paper
• Clinical mass spectrometry in neuroscience. Proteomics and peptidomics.

  2003cites this paper
• Pex8p: an intraperoxisomal organizer of the peroxisomal import machinery.

  2003cites this paper
• Between‐gel reproducibility of the human cerebrospinal fluid proteome

  2003cites this paper
• An improved method for tracking and reducing the void volume in nano HPLC–MS with micro trapping columns

  2003cites this paper
• Mechanisms of iron acquisition by the human pathogens Neisseria meningitidis and Neisseria gonorrhoeae.

  2003cites this paper
• Comparison of methods for sample preparation of individual rat cerebrospinal fluid samples prior to two-dimensional polyacrylamide gel electrophoresis

  2003influential citation
• Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in clinical chemistry.

  2003cites this paper
• The mitochondrial presequence translocase: an essential role of Tim50 in directing preproteins to the import channel.

  2002cites this paper